Effects of A1 Milk, A2 Milk and the Opioid-like Peptide β-Casomorphin-7 on the Proliferation of Human Peripheral Blood Mononuclear Cells
Biomolecules · 2024
DOI: 10.3390/biom14060690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Felix Gard und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Animal Physiology, Department of Veterinary Sciences, Ludwig Maximilian University of Munich, D-82152 Martinsried, Germany. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, Cell Proliferation, Milk, Endorphins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Milch.Bayern.
Abstract (Originalsprache)
Special attention is given to cow’s milk and its variants, with ongoing discussions about health-related impacts primarily focusing on the A1 variant in contrast to the A2 variant. The difference between these variants lies in a single amino acid alteration at position 67 of β-casein. This alteration is presumed to make the A1 variant more susceptible to enzymatic breakdown during milk digestion, leading to an increased release of the peptide β-casomorphin-7 (BCM-7). BCM-7 is hypothesized to interact with µ-opioid receptors on immune cells in humans. Although BCM-7 has demonstrated both immunosuppressive and inflammatory effects, its direct impact on the immune system remains unclear. Thus, we examined the influence of A1 and A2 milk on Concanavalin A (ConA)-stimulated human peripheral blood mononuclear cells (PBMCs), as well as the effect of experimentally digested A1 and A2 milk, containing different amounts of free BCM-7 from β-casein cleavage. Additionally, we evaluated the effects of pure BCM-7 on the proliferation of ConA-stimulated PBMCs and purified CD4+ T cells. Milk fundamentally inhibited PBMC proliferation, independent of the β-casein variant. In contrast, experimentally digested milk of both variants and pure BCM-7 showed no influence on the proliferation of PBMCs or isolated CD4+ T cells. Our results indicate that milk exerts an anti-inflammatory effect on PBMCs, regardless of the A1 or A2 β-casein variant, which is nullified after in vitro digestion. Consequently, we deem BCM-7 unsuitable as a biomarker for food-induced inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair of Animal Physiology, Department of Veterinary Sciences, Ludwig Maximilian University of Munich, D-82152 Martinsried, Germany.
- Chair of Pharmacology, Toxicology and Pharmacy, Department of Veterinary Sciences, Ludwig Maximilian University of Munich, D-80539 Munich, Germany.
ORCID-Profile: Hermann Ammer, Cornelia A Deeg
Förderung
- Milch.Bayern
Zitieren
APA
Gard, F., Flad, L. M., Weißer, T., Ammer, H., & Deeg, C. A. (2024). Effects of A1 Milk, A2 Milk and the Opioid-like Peptide β-Casomorphin-7 on the Proliferation of Human Peripheral Blood Mononuclear Cells. Biomolecules. https://doi.org/10.3390/biom14060690
Vancouver
Gard F, Flad LM, Weißer T, Ammer H, Deeg CA. Effects of A1 Milk, A2 Milk and the Opioid-like Peptide β-Casomorphin-7 on the Proliferation of Human Peripheral Blood Mononuclear Cells. Biomolecules. 2024. doi:10.3390/biom14060690
BibTeX
@article{Gard2024,
author = {Gard, Felix and Flad, Lili M and Weißer, Tanja and Ammer, Hermann and Deeg, Cornelia A},
title = {Effects of A1 Milk, A2 Milk and the Opioid-like Peptide β-Casomorphin-7 on the Proliferation of Human Peripheral Blood Mononuclear Cells},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14060690}
}
EUVIMED